Infectious diseases pose a significant threat to global health, necessitating reliable preclinical models to evaluate therapeutic agents and vaccines. Animal models are essential for evaluating these agents in appropriate in vivo environments that mimic human disease, offering critical insights into pathogenesis, immune responses, and treatment efficacy, ultimately aiding the development of safe and effective interventions.
At Aragen Bioscience, we offer specialized animal models for studying various infectious diseases, enabling you to explore both disease mechanisms and the effectiveness of potential treatments. Our expertise in this area allows for precise, reproducible results that aid in the progression of novel therapies. By utilizing these models, you can better understand disease progression and optimize drug and vaccine development strategies. We provide the following infectious disease models:
Advancing the understanding and treatment of respiratory diseases by providing comprehensive research and preclinical solutions to develop effective therapies for viral respiratory infections.
Advancing the understanding and treatment of respiratory diseases by providing comprehensive research and preclinical solutions to develop effective therapies for viral respiratory infections.
Addressing the complexities of gastrointestinal diseases with targeted research and advanced models, accelerating the development of therapies for GI infections.
Addressing the complexities of gastrointestinal diseases with targeted research and advanced models, accelerating the development of therapies for GI infections.
Driving antiviral therapy innovation by leveraging detailed research and preclinical models to evaluate and refine antiviral therapies for effective treatments against viral infections.
Driving antiviral therapy innovation by leveraging detailed research and preclinical models to evaluate and refine antiviral therapies for effective treatments against viral infections.
Offering in-depth immunogenicity studies to evaluate and optimize vaccine candidates, ensuring their safety and effectiveness in addressing both current and emerging infectious diseases.
Offering in-depth immunogenicity studies to evaluate and optimize vaccine candidates, ensuring their safety and effectiveness in addressing both current and emerging infectious diseases.
Aragen offers custom animal models for viral and bacterial infections, as well as vaccine immunogenicity, tailored to your research needs. Our experienced team can modify existing models or create new ones, supporting precise studies of disease mechanisms, immune responses, and therapeutic efficacy. Our team is committed to supporting your research at every step of the way, enabling translational research that bridges animal studies and human clinical outcomes.
Why Aragen?
Collaborate with Aragen for effective, customer-focused solutions that ensure the preclinical efficacy studies align with your project goals, advancing towards your drug development efforts. We offer: